These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3576653)

  • 21. A comparison of the relative sensitivities of factor VII and prothrombin time measurements in detecting drug interactions with warfarin.
    Pitsiu M; Parker EM; Aarons L; Holt B; Rowland M
    Eur J Clin Pharmacol; 1992; 42(6):645-9. PubMed ID: 1623906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.
    Schwartz JI; Bugianesi KJ; Ebel DL; De Smet M; Haesen R; Larson PJ; Ko A; Verbesselt R; Hunt TL; Lins R; Lens S; Porras AG; Dieck J; Keymeulen B; Gertz BJ
    Clin Pharmacol Ther; 2000 Dec; 68(6):626-36. PubMed ID: 11180023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of Danshen (Salvia miltiorrhiza) on pharmacokinetics and pharmacodynamics of warfarin in rats.
    Lo AC; Chan K; Yeung JH; Woo KS
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):257-62. PubMed ID: 1301354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects.
    Salazar DE; Dockens RC; Milbrath RL; Raymond RH; Fulmor IE; Chaikin PC; Uderman HD
    J Clin Pharmacol; 1995 Jul; 35(7):730-8. PubMed ID: 7560254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers.
    Davy M; Bird N; Rost KL; Fuder H
    Chemotherapy; 1999; 45(6):491-5. PubMed ID: 10567780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
    Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
    Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats.
    Chan K; Lo AC; Yeung JH; Woo KS
    J Pharm Pharmacol; 1995 May; 47(5):402-6. PubMed ID: 7494191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of beta-adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin after a single dose.
    Bax ND; Lennard MS; Tucker GT; Woods HF; Porter NR; Malia RG; Preston FE
    Br J Clin Pharmacol; 1984 May; 17(5):553-7. PubMed ID: 6329253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of vinpocetine on warfarin-induced inhibition of coagulation.
    Hitzenberger G; Sommer W; Grandt R
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):323-8. PubMed ID: 2272713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):45-50. PubMed ID: 9839766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in plasma warfarin levels and variations in steady-state prothrombin times.
    White RH; Zhou H; Romano P; Mungall D
    Clin Pharmacol Ther; 1995 Nov; 58(5):588-93. PubMed ID: 7586953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple doses of trandolapril do not affect warfarin pharmacodynamics.
    Meyer BH; Müller FO; Badenhorst PN; Luus HG; de la Rey N
    S Afr Med J; 1995 Aug; 85(8):768-70. PubMed ID: 8553147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of warfarin in man.
    Toon S; Hopkins KJ; Garstang FM; Rowland M
    Eur J Clin Pharmacol; 1987; 32(2):165-72. PubMed ID: 3582481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.
    Jiang X; Blair EY; McLachlan AJ
    J Clin Pharmacol; 2006 Nov; 46(11):1370-8. PubMed ID: 17050802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of safflower injection on the pharmacodynamics and pharmacokinetics of warfarin in rats.
    Liu Y; Liu S; Shi Y; Qin M; Sun Z; Liu G
    Xenobiotica; 2018 Aug; 48(8):818-823. PubMed ID: 28783419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of the relationship between the pharmacokinetics and the pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit.
    Breckenridge AM; Cholerton S; Hart JA; Park BK; Scott AK
    Br J Pharmacol; 1985 Jan; 84(1):81-91. PubMed ID: 3978316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary warfarin resistance. Investigation of a rare phenomenon.
    Alving BM; Strickler MP; Knight RD; Barr CF; Berenberg JL; Peck CC
    Arch Intern Med; 1985 Mar; 145(3):499-501. PubMed ID: 3977518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of etoricoxib on the pharmacodynamics and pharmacokinetics of warfarin.
    Schwartz JI; Agrawal NG; Hartford AH; Cote J; Hunt TL; Verbesselt R; Eckols DR; Gottesdiener KM
    J Clin Pharmacol; 2007 May; 47(5):620-7. PubMed ID: 17442687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin sodium: steady-state plasma levels and patient age.
    Hotraphinyo K; Triggs EJ; Maybloom B; Maclaine-Cross A
    Clin Exp Pharmacol Physiol; 1978; 5(2):143-9. PubMed ID: 648034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.